News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biofusion Launches Company To Develop Schizophrenia Treatments


2/22/2006 1:27:54 PM

AIM-listed Biofusion plc said it is creating a company called Genophrenix Ltd, to develop packages of proprietary therapeutic targets and compounds that could be licensed to pharmaceutical companies focused on developing new treatments for schizophrenia.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES